Friday, January 27, 2023

One dose of hemophilia medicine costs 21 million Dollars

Must Read

The world’s most expensive drug has been approved. One dose of which costs 21 million US dollars. US regulators have approved a hemophilia B gene therapy developed by CSL Behring, a US company that makes drugs for complex and rare diseases. News from Bloomberg and The Indian Express.

According to reports, just one dose of this medicine will make the hemophilia patient wholly cured. The drug can reduce bleeding by 54 percent for more than a year after a single application.

The drug freed 94 percent of patients from time-consuming and expensive infusions of factor IX, the study found. Currently, this method is used to control potentially critical conditions in patients with hemophilia.

Although the price of the drug is a little higher than expected, we think it has the potential to be successful, the manufacturer said.

Among the expensive drugs, Swiss-US drug company Novartis AG’s Zolgensma was previously approved in 2019 for treating spina bifida in children. The price of which is 21 million US dollars. In addition, at the beginning of this year, the cost of Zinteglo, a thalassemia drug manufactured by Bluebird Bio Inc., was 2.8 million US dollars.

According to Unicure, more than 1.5 million people in the United States and Europe have hemophilia B. Patients with hemophilia A are about five times more likely to have hemophilia than B.

Note that hemophilia is a bleeding disorder passed down through generations. Multiple factors or factors are involved in blood clotting after a cut in the body. Among them, if the production level of two particular components decreases, there is a problem with blood clotting. Bleeding may begin in this situation with or without the slightest injury; This is called hemophilia.

Book NOW spot_img
Latest News

Kuwaiti government resigns after dispute with parliament

Market Desk (online): Prince Sheikh Meshal al-Ahmad al-Sabah, who has taken over most of the emir’s duties, last year...

More Articles Like This